Menstrual bleeding: diagnosis and treatment

Андреева, Елена; Sheremetyeva, E.V.

doi:10.18565/aig.2019.5.186-192

Cited by 2 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Содержит двухвалентное железо, за счет постепенного высвобождения железа хорошо переносится. анеМия и обильные Маточные кроВотечения В РФ хотя бы один эпизод АМК в анамнезе имеет каждая вторая пациентка репродуктивного возраста [7,19]. При этом часто встречающейся и нерешенной в практике врача-гинеколога проблемой являются обильные маточные кровотечения (ОМК).…”

Section: клиническое наблюдение №unclassified

“…По данным FIGO (2018 г. ), только каждая вторая женщина с ОМК обращается за медицинской помощью [7]. Ранее одним из критериев обильных менструаций считалась ежемесячная кровопотеря более 80 мл, однако проведенное эпидемиологическое исследование с участием 475 женщин показало, что 41% женщин с кровопотерей более 80 мл оценили свои менструации как нормальные и необильные.…”

Section: клиническое наблюдение №unclassified

“…Статистика говорит о четких гендерных различиях в частоте встречаемости железодефицитных состояний: если в популяции от анемии страдают лишь 12,7% мужчин, то среди женщин фертильного возраста эта цифра достигает 30,2%. ЖДА является третьей по распространенности причиной временной потери трудоспособности у женщин в возрасте 15-44 лет [6,7].…”

Section: Introductionunclassified

See 2 more Smart Citations

Prevention and treatment for iron-deficiency anemia in obstetrical gynecological practice

Селихова¹,

Soltys²,

Kalacheva³

2020

Russian Journal of Woman and Child Health

View full text Add to dashboard Cite

The prevalence of iron-deficiency anemia (IDA) is steadily increasing. IDA is more common in women of reproductive age, pregnant women, and adolescent girls thus accounting for the importance of this issue in obstetrics and gynecology. Abnormal uterine bleeding (AUB) is one of the most common causes of IDA both in the puberty and reproductive period which requires hemostasis as well as addressing iron deficiency. A high rate of IDA was also reported in women with pelvic inflammatory diseases; this should considered when managing this large group of gynecological patients. The treatment for anemia or latent iron deficiency is performed for a long time, therefore, the selection of a medication is particularly important. Peroral Tardyferon® containing 80 mg of iron meets all modern-day requirements for anti-anemic drugs and is recommended for anemia resulting from AUB both in women of reproductive age and adolescent girls. Case studies illustrate high efficacy and good tolerability of this medication. KEYWORDS: iron-deficiency anemia, pregnancy, abnormal uterine bleeding in puberty, heavy menstrual bleeding, genital inflammation, high efficacy, compliance. FOR CITATION: Selikhova М.S., Soltys P.A., Kalacheva L.S. Prevention and treatment for iron-deficiency anemia in obstetrical gynecological practice. Russian Journal of Woman and Child Health. 2020;3(4):276–281. DOI: 10.32364/2618-8430-2020-3-4-276-281.

show abstract

Section: клиническое наблюдение №unclassified

Section: Introductionunclassified

See 1 more Smart Citation

Prevention and treatment for iron-deficiency anemia in obstetrical gynecological practice

Селихова¹,

Soltys²,

Kalacheva³

2020

Russian Journal of Woman and Child Health

View full text Add to dashboard Cite

show abstract

Effectiveness of an Intrauterine Contraceptive Containing Levonorgestrel (Mirena) in the Treatment of Heavy Menstrual Bleeding

Калинкина

2021

Mediko-farmacevtičeskij žurnal "Pulʹs"

View full text Add to dashboard Cite

Levonorgestrel-containing intrauterine system Mirena refers to the first-line therapy of heavy menstrual bleeding (OMC) according to the recommendations of different countries. The efficacy, acceptability, and quality of life of women using Mirena are similar to those in the surgical treatment of abnormal uterine bleeding, including endometrial ablation and hysterectomy. The clinical case presented in this study of the management of a patient with heavy menstrual bleeding allowed us to demonstrate the effectiveness of the levonorgestrel-containing Mirena intrauterine system in OMC. The patient was observed in the consultative polyclinic of the V. D. Seredavin State Medical University. At the initial treatment, she complained of heavy menstruation, decreased performance, weight gain, and periodic increases in blood pressure. After a comprehensive clinical examination, taking into account heavy menstruation, a decrease in the quality of life, as well as the need for contraception, the introduction of the Mirena IUD was recommended. A year after the introduction of the IUD, the patient had amenorrhea. 5 years after the introduction of the Mirena IUD, the patient developed hot flashes, increased sweating, vaginal dryness, mood swings, sleep disorders, accompanied by an increase in FSH levels. The intrauterine system was removed and a new IUD - Mirena-was installed as a component of menopausal hormone therapy. After 2 months from the beginning of therapy, the complaints were completely stopped, the state of health is satisfactory, dryness in the vagina does not bother. Thus, the use of the LNG – IUD Mirena was effective for the relief of heavy menstrual bleeding, in addition, in women of this age group, it is possible to continue using the levonorgestrel-containing intrauterine system Mirena as a component of menopausal hormone therapy.

show abstract

Menstrual bleeding: diagnosis and treatment

Cited by 2 publications

References 0 publications

Prevention and treatment for iron-deficiency anemia in obstetrical gynecological practice

Prevention and treatment for iron-deficiency anemia in obstetrical gynecological practice

Effectiveness of an Intrauterine Contraceptive Containing Levonorgestrel (Mirena) in the Treatment of Heavy Menstrual Bleeding

Contact Info

Product

Resources

About